Plasma One Launches to Herald a New Era of Stablecoin Banking
19.6.2026 15:29:00 EEST | Business Wire | Press release
Plasma has today announced the launch of Plasma One, its flagship financial product designed to make digital dollars usable for everyday spending, sending and earning.
Plasma One is designed to make stablecoins feel like money, only better - more accessible, reliable and efficient. For years, stablecoin adoption has been held back by a fragmented system and poor user experience. We have seen wallets in one place, exchanges in another, and costly off-ramps standing between digital dollars and daily life. Plasma One brings that experience together in a single app, giving users a simple way to spend, send and earn with stablecoins from one account with zero fees.
Headquartered in London, the city that gave rise to Revolut, Wise and Monzo, Plasma is making a bigger bet, that the next generation of consumer banking will be built on stablecoin rails, not legacy banking infrastructure.
Underneath Plasma One is the Plasma Network, Plasma’s own blockchain, purpose-built to move stablecoins instantly, cheaply and reliably at global scale. By owning the infrastructure beneath the product, Plasma is building more than an app. It is creating a vertically integrated financial stack for stablecoins, spanning blockchain infrastructure, liquidity, payments, licensing and consumer distribution.
Paul Faecks, Founder and Chief Executive Officer at Plasma, said: “Stablecoins will not become part of everyday banking through another app sitting on top of someone else’s rails. They need a product that brings the entire experience together. That’s what Plasma One is built to do. By combining the network, payments stack, and user experience into a single platform, Plasma One makes it possible to spend, send, save, and earn with digital dollars as seamlessly and reliably as people use money today.”
From launch, Plasma One delivers the full feature set users expect from a modern neobank:
- Deposit - Add stablecoins directly from your wallet, or fund your account in USD, EUR, GBP, MXN and BRL through dedicated virtual accounts connected to local payment rails, including SEPA, Faster Payments and ACH.
- Spend - Pay with your Plasma One Visa card across 180+ countries. In addition to up to 4% cashback on qualified purchases, Plasma One rewards AI power users with dedicated benefits: the Core tier offers 5% cashback on eligible AI spend plus a year of ChatGPT Go, while the Platinum tier offers 10% cashback on eligible AI spend, along with an annual subscription to ChatGPT Go and Claude Pro.
- Send - Move money across borders in seconds, with unlimited free transfers settled on the Plasma Network.
- Earn - Put idle balances to work with seamless access to competitive on-chain yields.
Zaheer Ebtikar, Chief Strategy Officer at Plasma, said:“Global stablecoin supply has roughly doubled in the last two years, but supply isn’t adoption. Adoption is when stablecoins become simple enough for anyone to use every day. With Plasma One, users can onboard in minutes, add digital dollars, spend with a card, send money globally, and put balances to work from one product. We are taking the efficiency of blockchain technology and combining it with the familiarity of money, creating an experience that feels faster, more global and more useful than traditional finance. That is the standard stablecoins need to reach billions of people.”
Plasma One’s private beta has already amassed 5,000 weekly active users and today's launch is just the beginning - over the coming months, Plasma will add new capabilities for consumers and businesses alike as it continues building out the infrastructure to make stablecoin banking work at scale.
About Plasma
Plasma builds financial products for consumers and businesses using stablecoins instead of traditional banking rails. Plasma One, its first product, lets users send, spend, save, and earn with stablecoins. Everything runs on Plasma's own blockchain, built from the ground up for speed, reliability, and scale.
Disclaimer: Plasma is a financial technology company, not a regulated financial institution, bank, money services business or investment advisor. Plasma does not custody your assets. The stablecoin assets in your Plasma One account are owned and custodied by you. The value of any cryptocurrency, including stablecoin assets pegged to fiat currency, commodities, or any other asset, may go to zero. Stablecoin balances are not bank deposits.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260619440985/en/
Contacts
Media Contact: Kishan Naran - kishan.naran@wachsman.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IQM Appoints Craig Ciesla, Former Illumina VP, as CTO; Inés de Vega Becomes Chief Scientist19.6.2026 10:00:00 EEST | Press release
IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointments of Dr. Craig Ciesla as Chief Technology Officer (CTO) and Dr. Inés de Vega as Chief Scientist, as she transitions from her role as Vice President of Quantum Solutions, deepening IQM´s leadership as the company prepares for its planned Nasdaq listing through a merger with Real Asset Acquisition Corp. (Nasdaq: RAAQ). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260619693929/en/ From left to right: Dr. Inés de Vega, Chief Scientist, and Dr. Craig Ciesla, Chief Technology Officer. Ciesla, an experienced deep tech executive with more than 25 years delivering products across multiple industries from startups to Fortune 500 companies, will advance IQM's technology strategy and drive its implementation into systems and products. De Vega, meanwhile, will be responsible for ensuring scientific feasibility and system-level
Teijin Receives Approval for Additional Indications of XEOMIN ® for Cervical Dystonia and Blepharospasm in Japan19.6.2026 10:00:00 EEST | Press release
Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, and Merz Therapeutics GmbH, a leading player in neurology-focused specialty pharma, jointly announced today that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved the additional indications for XEOMIN® (incobotulinumtoxinA) for the treatment of cervical dystonia and blepharospasm. This approval represents the fourth and fifth indications for XEOMIN® authorized in Japan, alongside its existing approvals for the treatment of upper limb spasticity, lower limb spasticity and chronic sialorrhea. Cervical dystonia is a focal dystonia characterized by involuntary contractions of the neck muscles, resulting in abnormal or repetitive movements and postures.1 Blepharospasm is also a focal dystonia, characterized by excessive involuntary contractions of the muscles surrounding the eye.2 Both conditions significantly impact patients’ quality of life. The approval by MHLW is based on Phase III clinic
Incyte Japan Announces Approval of Minjuvi ® (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)19.6.2026 09:00:00 EEST | Press release
Incyte Biosciences Japan G.K. today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Minjuvi® (tafasitamab) in combination with lenalidomide for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). “This approval provides a new option for patients in Japan living with relapsed or refractory DLBCL, an aggressive disease with historically limited treatment options,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “We are committed to helping address critical unmet needs for patients and their families affected by this challenging cancer.” DLBCL is the most common subtype of non-Hodgkin lymphoma and is an aggressive malignancy of B lymphocytes. While many patients respond to initial therapy, outcomes remain poor for those with relapsed or refractory disease, particularly for patients who are not eligible for autologous stem cell transplant.1 The approval is based on results from the MOR208C203 Trial: L
Amazfit Introduces Helio Strap Pro, Bringing Body-Worn Movement Intelligence to HYROX and Hybrid Training18.6.2026 20:07:00 EEST | Press release
Amazfit, a leading global smart wearable brand owned by Zepp Health (NYSE: ZEPP), today announced Helio Strap Pro, a body-worn training system designed to help HYROX and hybrid athletes better understand how their bodies perform under load. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260618031434/en/ Amazfit Introduces Helio Strap Pro, Bringing Body-Worn Movement Intelligence to HYROX and Hybrid Training Building on the screen-free Helio Strap, Helio Strap Pro adds a dedicated waist-mounted motion sensor that captures core-body movement and stability during training. Combined with upper-arm heart-rate sensing and compatible Amazfit smartwatches, the system provides a more complete picture of cardio effort, movement quality and muscle load than wrist-based tracking alone. Helio Strap Pro represents the next evolution of Amazfit's Hybrid Training System, extending performance tracking beyond heart rate to help athletes bett
HyperLight Announces $80 Million Series C to Accelerate TFLN Deployment for AI Infrastructure18.6.2026 18:30:00 EEST | Press release
HyperLight Corporation (“HyperLight”), a leader in thin-film lithium niobate (TFLN) photonics, today announced the closing of an $80 million Series C financing round led by MediaTek. The round includes participation from UMC Capital, Jabil, Foxconn, EDBI (arm of SG Growth Capital, the investment platform of the Singapore Economic Development Board and Enterprise Singapore), CDIB-TEN Capital, and Qatar Investment Authority (QIA), as well as strategic investors from leading silicon IC and networking companies. Existing investors Summit Partners, The Engine, Foothill Ventures, and Xora Innovation continue to actively support the company’s growth. The financing brings together companies across the AI infrastructure value chain — including silicon ICs, foundry manufacturing, electronics manufacturing services, networking, and global infrastructure investment — reflecting broad ecosystem support for scaling TFLN photonics into production. “This financing is about more than capital — it is ab
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom